<DOC>
	<DOCNO>NCT00519116</DOCNO>
	<brief_summary>The study evaluate renal graft function ( base calculate creatinine clearance ) 6 month kidney transplantation patient receive either regimen 'reduced-dose ' tacrolimus + sirolimus + corticosteroid regimen 'standard-dose ' tacrolimus + sirolimus + corticosteroid .</brief_summary>
	<brief_title>Study Comparing Standard Dose Reduced Dose Tacrolimus With Sirolimus Renal Transplant Patients</brief_title>
	<detailed_description>The study evaluate renal graft function ( base calculate creatinine clearance ) 6 month kidney transplantation patient receive either regimen 'reduced-dose ' tacrolimus + sirolimus + corticosteroid regimen 'standard-dose ' tacrolimus + sirolimus + corticosteroid . The two treatment group also compare respect incidence acute graft rejection 6 month patient graft survival 6 month transplantation .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Inclusion criterion : At least 18 year age Endstage renal disease patient receive primary secondary renal allograft cadaveric , livingunrelated , livingrelated mismatch donor Patients secondary transplant must maintain primary graft least 6 month Exclusion criterion : Planned antibody induction Multiple organ transplant History malignancy within five year enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>